4//SEC Filing
TALEVICH JAMES R 4
Accession 0001209191-18-029958
CIK 0000811240other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 5:48 PM ET
Size
12.4 KB
Accession
0001209191-18-029958
Insider Transaction Report
Form 4
BIOLASE, INCBIOL
TALEVICH JAMES R
Director
Transactions
- Exercise/Conversion
Common Stock
2018-05-11+7,394→ 20,374 total - Exercise/Conversion
Restricted Stock Unit
2018-05-11−7,394→ 0 total→ Common Stock (7,394 underlying) - Award
Restricted Stock Unit
2018-05-14+18,208→ 18,208 total→ Common Stock (18,208 underlying) - Award
Restricted Stock Unit
2018-05-14+91,379→ 109,587 total→ Common Stock (91,379 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F2]On May 10, 2017, the reporting person was granted 35,211 restricted stock units, which vested on May 11, 2018. On May 10, 2018, the Company issued a press release announcing that, at the Annual Meeting, the Company's stockholders approved a proposal to amend the Company's Restated Certificate of Incorporation to effect a reverse stock split of Company common stock at a ratio of not less than 1-for-5 and not more than 1-for-15, with the final ratio to be determined by the Board. Immediately after the Annual Meeting, the Board approved the reverse stock split at a ratio of one post-split share for every five pre-split shares.
- [F3]The restricted stock units vest as follows: (i) two-fifths of the restricted stock units vest on December 31, 2018, and (ii) three-fifths of the restricted stock units vest on December 31, 2019.
- [F4]The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award.
Documents
Issuer
BIOLASE, INC
CIK 0000811240
Entity typeother
Related Parties
1- filerCIK 0001243895
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 5:48 PM ET
- Size
- 12.4 KB